ROBERTS BRANDI (Chief Financial Officer) sold 0.8% of their position (3.38K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $123.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/30/2026ACC: 0001104659-26-112058
Officer· Chief Financial Officer
Since Feb 2026
-3.38K
Net shares
Net seller
$123.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.38K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−3.38K
Price / share
$36.57
Trade value
$123.50K
% of position
0.8%
9/25/2026
397.90K→394.53K
Total
Net shares
−3.38K
Net value
-$123.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/25/2026 | S · Sale | −3.38K | $36.57 | $123.50K | 0.8% | 397.90K | 394.53K |
| Total | −3.38K | -$123.50K | ||||||
Derivative Transactions0
No derivative transactions reported